A spiration pneumonia is an alveolar infection stemming from inhalation of the pathogenic material in the oropharynx \[[@ref1]\]. Demographic factors as advanced age, male gender, comorbidities as dysphagia, diabetes mellitus, severe dementia, deletion of angiotensin -converting enzyme-1, genotype, bad oral hygiene, Parkinson's disease, malnutrition medications as antipsychotics, proton pump inhibitors, and ACE-inhibitors have been demonstrated as risk factors for aspiration pneumonia \[[@ref2]\].

Aspiration pneumonia constitutes 5-15% of community-acquired pneumonia, and it is still responsible for 20% of community-acquired pneumonia among elder people, and ranks second among the most frequently seen nosocomial infections after urinary tract infections \[[@ref1], [@ref3], [@ref4]\]. Actuıal incidence of aspiration pneumonia may be higher. As observed by many authors, indeed 50% of healthy individuals, and 70% of the elder population have aspirated something during their sleep \[[@ref5], [@ref6]\]. Aspiration pneumonia is one of the most important causes of hospitalization especially of elder people, those with neurological problems or individuals staying in nursing homes.

In the community, the number of geriatric patients increase in parallel with prolongation of mean life span. In addition, higher incidence of comorbidities as dementia, stroke, Alzheimer's disease, diabetes, and hypertension also increases rates of hospitalization. The objective of this study was to evaluate mortality, nutritional status, sociodemographic characteristics, and factors effective on martality.

MATERIALS AND METHODS {#sec1-2}
=====================

Medical files of the patients aged 18 and over who were hospitalized in the Clinics of Internal Medicine of Istanbul Medeniyet University Goztepe Training and Research Hospital between January 1, 2010, and January 1, 2013 with the diagnosis of pneumonia were retrieved from otomation system, and patients' archives of the hospital and analyzed, and included in the study. The approval (date: January 24, 2013; decision \#: 30/H) of the Ethics Committee of Istanbul Medeniyet University Goztepe Training and Research Hospital was obtained. During the study period, principles of Helsinki Declaration were taken into consideration.

Study design: {#sec2-1}
-------------

On patient registration forms, age, gender, diagnosis of admission in the Service of Internal Medicine, nutritional status, duration of hospitalization, clinical, and laboratory information, and prognoses (rates of discharge or exitus), comorbidities (chronic obstructive pulmonary disease, diabetes mellitus, heart failure, hypertension, chronic renal disease, chronic ischemic heart disease, atrial fibrillation, dementia, Parkinson's disease, and cerebrovascular disease) were recorded. Mortality rates, nutritional status, frequency of comorbidities, hematological, and biochemical data, and their relation with mortality were evaluated. Data of the patients discharged, and exited were also compared.

Diagnosis of aspiration pneumonia: {#sec2-2}
----------------------------------

Despite lack of defined, and precise diagnostic criteria diagnosis of aspiration pneumonia was made based on witnessed event of aspiration or strong evidence of suspect aspiration (abnormal swallowing function, and dysphagia) and confirmation of findings of pulmonary inflammation \[[@ref1]\].

Laboratory parametres: {#sec2-3}
----------------------

From patients'files, whole blood counts, biochemical data (glucose, urea, uric acid, creatinine, sodium, potassium, phosphorus, aspartate aminotransferase, alanine transferase, total bilirubin, indirect bilirubin, gamma glutamyl transferase, alkaline transferase, lactate dehydrogenase, cholesterol, triglyceride, HDL-cholesterol, LDL-cholesterol, creatinine kinase, CK-MB, iron, iron-binding capacity, amilase, lipase, protein, albumin, sedimentation rate, C-reactive protein, aPTT, INR, HbA1c, TSH, freeT3, free T4, ferritin, folic acid, and vitamin B12) were recorded.

Statistical analyses were performed using SPSS for Windows V.21.0 program. Before analyses, fitness of variables to normal distribution pattern was analyzed using Kolmogorov- Smirnov test. Continuous variables were expressed as mean±SD. Classified and numerical data were analyzed using chi-square test, Student's t test, and Mann-Whitney U test, respectively. Independent factors effective on mortality, and results of logistic regression analysis were expressed as levels of significance, and estimated relative risks (odds ratio-OR), and 95% confidence intervals (95% CI) Results at a level of significance of p\<0.05 within 95% confidence interval were accepted as statistically significant values.

RESULTS {#sec1-3}
=======

A total of 204 (115 male, and 89 female) patients diagnosed as aspiration pneumonia with a mean age of 77±13 years, and duration of hospitalization of 11±9 days were included in the study. Median mortality rate was 24.5 percent. Eighty-eight percent of the patients were older than 65 years of age. Nearly 56% of the deaths occurred within the first 3 days. At first admission, the patients were receiving their nutrients through oral route (n=174; 85%) or percutaneous endoscopic gastrostomy (PEG) (n=30; 15%). Distribution of demographic data, and comorbidities are given in [Table 1](#T1){ref-type="table"}. The most frequently associated comorbidities were dementia (49%), hypertension (43%), cerebrovascular events (42%), and diabetes mellitus (31%). Hospitalization rates were higher in discharged patients when compared with exited patients (p=001).

###### 

Demographic characteristics and comorbidities of the patients

                                      Total (n=204)   Discharged (n=154)   Exited (n=50)   p                    
  ----------------------------------- --------------- -------------------- --------------- ------- ------- ---- ----
  Age, years                          77±13           78±13                75±16           NS                   
  Gender, M/F                         115/89                               89/65                   26/24        NS
  Duration of hospitalization, days   11±9            12±7                 7±12            0.001                
  Comorbidities                                                                                                 
   Renal diseases                     14              6.6                  8               4       6       3    NS
   Diabetes mellitus                  64              31                   42              21      32      15   NS
   Hypertension                       91              45                   65              33      26      13   NS
   Congestive heart failure           27              13                   19              9       18      5    NS
   Atrial fibrillatiion               26              12                   14              7       12      6    NS
   Chronic ischemic heart disease     34              17                   24              12      10      5    NS
   Dementia                           104             49                   83              42      21      11   NS
   Parkinsonism                       20              10                   18              9       2       1    NS
   Cerebrovascular disease            89              42                   69              35      20      10   NS

Laboratory data are given in Tables [2](#T2){ref-type="table"}, and [3](#T3){ref-type="table"}. When compared with survived patients, in exited patients neutrophil/lymphocyte ratio, urea, uric acid, ALP, LDH, phosphorus, prothrombin time were relatively higher (for all, p\<0.05), while TSH, and free T3 levels were lower (for all, p\<0.05).

###### 

Hematological parameters of patients with aspiration pneumonia

                                               Total (n=204)      Discharged (n=154)   Exited (n=50)      p
  -------------------------------------------- ------------------ -------------------- ------------------ ------
  Hematocrit (%)                               34.5±7.5           34.7±8.1             33.8±5.5           NS
  Platelet (10^3^/mm^3^)                       284±140            292±142              258±126            NS
  Leukocyte (10^3^/mm^3^)                      13447±6180         13200±6150           14200±6275         NS
  Neutrophil (10^3^/mm^3^)                     11380±7670         11196±8160           11950±5960         NS
  Lymphocyte (10^3^/mm^3^)                     1300 (900-1800)    1300 (900-1800)      800 (700-1400)     0.02
  Neutrophil/Lymphocyte                        7.6 (4.3-12.3)     7.1 (3.8-11.4)       8.7 (4.5-19.7)     0.05
  Neutrophil/Leukocyte                         0.82 (0.74-0.88)   0.82 (0.75-0.87)     0.82 (0.76-0.91)   NS
  Lymphocyte/Leukocyte                         0.13±0.08          0.13±0.058           0.11±0.08          NS
  MCV^[1](#t2f1){ref-type="table-fn"}^ (fL)    88 (84-94)         88 (84-93)           84 (82-95)         NS
  RDW^[2](#t2f2){ref-type="table-fn"}^ (%)     15.5±2.5           15.3±2.2             15.7±3.1           NS
  MPV^[3](#t2f3){ref-type="table-fn"}^ (fL)    9.8±6.9            9.9±7.9              9.4±1.3            NS
  PDW^[4](#t2f4){ref-type="table-fn"}^ (GSD)   16.3 (15.6-17.5)   16.3 (15.6-17.5)     16.3 (15.8-17.5)   NS
  Iron (µgr/dL)                                23 (14-37)         23 (14-35)           40 (18-48)         NS
  Folate (pg/ml)                               8.1±5.5            8.1±5.6              7.9±5.2            NS
  Vitamin B12 (pg/ml)                          320 (198-520)      316 (198-542)        542 (270-970)      0.05

MCV: Mean corpuscular volume;

RDW: Erythrocyte distribution width (%);

MPV: Mean platelet volume;

PDW: Platelet distribution width.

###### 

Biochemical parameters of the patients

                                                             Total (n=204)      Exited (n=50)      Discharged (n=154)   p         
  ---------------------------------------------------------- ------------------ ------------------ -------------------- --------- --
  Glucose (mg/dL)                                            109 (82-162)       149 (85-178)       108 (82-145)         0.02      
  Urea (mg/dL)                                               61 (41-113)        79 (46-156)        56 (38-101)          0.002     
  Uric acid (mg/dL)                                          5 (3.5-6.5)        5.9 (4.1-8.2)      4.9 (3.4-5.9)        0.003     
  Creatinine (mg/dL)                                         0.9 (0.6-1.4)      1.3 (0.7-2.6)      0.9 (0.6-1.2)        0.015     
  Sodium (mEq/L) (Mean±SD)                                   141±10             140±10             141±10               NS        
  Potassium (mEq/L) (Mean±SD)                                4.2 (3.7-4.5)      4.3 (3.9-4.9)      4.1 (3.6-4.4)        NS        
  AST^[1](#t3f1){ref-type="table-fn"}^ (U/L)                 26 (18-49)         30 (22-69)         25 (18-42)           0.02      
  ALT^[2](#t3f1){ref-type="table-fn"}^ (U/L)                 20 (13-35)         25 (13-41)         20 (13-32)           0.04      
  T bilirubin^[3](#t3f3){ref-type="table-fn"}^ (mg/dL)       0.56 (0.37-0.8)    0.64 (0.47-0.89)   0.53 (0.36-0.88)     0.02      
  I Bilirubin^[4](#t3f4){ref-type="table-fn"}^ (mg/dL)       0.41 (0.28-0.6)    0.45 (0.23-0.65)   0.41 (0.27-0.62)     0.05      
  GGT^[5](#t3f5){ref-type="table-fn"}^ (U/L)                 29 (16-62)         48 (16-98)         27 (17-53)           0.01      
  ALP^[6](#t3f6){ref-type="table-fn"}^ (U/L)                 79 (64-100)        92 (73-114)        76 (61-93)           0.003     
  LDH^[7](#t3f7){ref-type="table-fn"}^ (U/L)                 244 (211-329)      262 (227-367)      246 (207-288)        0.007     
  Cholesterol (mg/dL) (Mean±SD)                              136±45             142±64             134±39               NS        
  Triglyceride (mg/dL) (Mean±SD)                             115±70             129±65             111±73               NS        
  HDL-C^[8](#t3f8){ref-type="table-fn"}^ (mg/dL) (Mean±SD)   33±15              32±18              33±14                NS        
  LDL-C^[9](#t3f9){ref-type="table-fn"}^ (mg/dL) (Mean±SD)   83±37              85±49              82±33                NS        
  CK^[10](#t3f10){ref-type="table-fn"}^ (U/L)                106 (47-224)       77 (29-109)        122 (52-227)         NS        
  Protein (g/dL) (Mean±SD)                                   6.1±0.8            6.1±0.7            6.2±0.8              NS        
  HbA1c^[11](#t3f11){ref-type="table-fn"}^ (%)               5.8 (5.5-6.7)      5.8 (5.6-7)        5.7 (5.5-6.6)        NS        
  Phosphorus (mEq/L)                                         3.3 (2.8-4)        4 (3.2-4.7)        3.2 (2.7-3.7)        \<0.001   
  INR^[12](#t3f12){ref-type="table-fn"}^ (%)                 1.25 (1.18-1.36)   1.32 (1.25-1.45)   1.23 (1.16-1.3)      0.008     
  TSH^[13](#t3f13){ref-type="table-fn"}^ (uIU/mL)            1.12 (0.66-2.26)   0.99 (0.33-1.91)   1.33 (0.69-2.34)     0.059     
  FreeT3^[14](#t3f14){ref-type="table-fn"}^ (pgr/mL)         2.06 (1.74-2.30)   1.85 (1.59-2.15)   2.12 (1.81-2.33)     0.005     
  FreeT4^[15](#t3f14){ref-type="table-fn"}^ (ng/dL)          1.06 (0.87-1.23)   1.08 (0.89-1.23)   1.06 (0.87-1.23)     NS        

AST: Acid transferase;

ALT: Alkaline transferase;

T. bilirubin: Total bilirubin;

I. Bilirubin: Indirect bilirubin;

GGT: Gamma glutamyl transferase;

ALP: Alkaline phosphatase;

LDH: Lactate dehydrogenase;

HDL-C: High-density lipoprotein cholesterol;

LDL-C: Low-density lipoprotein cholesterol;

CK: Creatinine kinase;

HbA1c: Hemoglobin A1c;

INR: International normalized ratio;

TSH: Thyroid stimulating hormone;

Free T3: Triiodothyronine;

FreeT4: Thyroxine.

In a multivariate logistic regression analysis where factors effective on mortality were evaluated, increased uric acid levels, and neutrophil/lymphocyte ratios predicted mortality. In these patients uric acid levels, and neutrophil/lymphocyte ratios were higher in exited patients when compared with those discharged. Uric acid levels higher than 5.35 mg/dL (AUC=0.620) have 61.3% sensitivity, and 62% specificity in predicting mortality, however neutrophil/lymphocyte ratios over 10.63 (AUC=0.608) have 44% sensitivity, and 74% specificity in predicting mortality.

DISCUSSION {#sec1-4}
==========

In this study, 88.2% of the cases with aspiration pneumonia were over 65 years of age, and at admission the patients were fed via oral (85%) route or PEG (15%). Development of aspiration pneumonia had no effect on the patients' nutritional status (oral, nasogastric tube or PEG). The most frequently seen comorbidities were dementia, hypertension, cerebrovascular event, and diabetes mellitus. Mortality rate was 24.5% (56% within the first 3 days). Increase in neutrophil/lymphocyte ratios (NLRs), and uric acid levels were found to be related to mortality (for both, p\<0.05).

Demographic characteristics as advanced age, and male gender were known to be risk factors for aspiration pneumonia. In a study where mortality rates in inpatients with aspiration pneumonia were investigated, median age of the patients, and percentage of male patients were reported as 76.7 years, and 50.2%, respectively \[[@ref7]\]. In a prospective study on 62 cases performed by Tokuyasu et al. median age of the patients was 86.6 years, and male patients constituted 56.8% of the study population \[[@ref8]\]. In their retrospective study by Fidan et al. on 31 cases with aspiration pneumonia, median age of their study population was 61 years, while 55% of their patients consisted of male patients \[[@ref9]\]. In our study median age of 204 patients diagnosed as aspiration pneumonia in the clinics of internal medicine was 77 years, and 56% of the study population comprised of male patients. Similar to the literature findings, distribution of aspiration pneumonia was nearly the same in both genders, and medain age of the patients was similar to that encountered during literature reviews.

Aspiration can cause serious problems especially in patients with dementia. In a study by Feinberg et al. the authors performed a study in nursing home patients using modified videofluoroscopy guided swallowing test with barium, and detected events of major, and minor aspiration in 24, and 50% of the patients, respectively \[[@ref10]\]. In a study by Metan et al. the most frequent comorbidity in their patients with aspiration pneumonia was neurological diseases (78%) which were detected in 20% of the patients with dementia \[[@ref11]\]. Still in our study, great majority of the patients with aspiration pneumonia had a neurological disease (cerebrovascular disease, dementia, Parkinson's disease), and 49% of the study population consisted of patients with dementia.

Relationship between enteral nutrition, and complication of aspiration is already acknowledged. In patients on tube feeding, and those dependent on others for oral hygiene, the risk of aspiration was observedly 20-fold higher when compared with healthy individuals \[[@ref12], [@ref13]\]. Nakajoh et al. investigated one-year incidence of aspiration pneumonia in patients who experienced a cerebrovascular event, and observed its incidence as 54.3% in dysphagic patients on oral intake which was higher than dysphagic cases on tube feeding (13.2%). The incidence of aspiration pneumonia was 64.3% in bedridden patients fed through nasogastric tube \[[@ref14]\]. Our patients were fed via PEG (15%) or through oral route (85%) at admission. This finding suggests that aspiration pneumonia is more frequently seen in elder patients fed through oral route, and alimentation through PEG has not any prophylactic effect in these cases.

Though mortality rates of aspiration pneumonia ranged between 20, and 50%, in some studies higher rates up to 80% have been reported \[[@ref15], [@ref16], [@ref17], [@ref18]\]. In our study median rate of mortality was found as 24.5% in compliance with the literature findings. In cases with aspiration pneumonia, disparities between mortality rates can be attributed to the lack of definitive diagnostic criteria defined for aspiration pneumonia, and higher mortality rates can be associated with advanced age of these patients, and concomitant diseases.

In recent years an index which reflects both acute inflammation, and lymphopenia developing after acute physiologic stress has been started to be used. This index is a neutrophil/lymphocyte ratio which has been reported to be a good marker of the inflammatory state \[[@ref19]\]. Duffy et al. divided 1046 patients into 3 groups (mean NLR 1.7±0.5; 3.2±0.6; 11.2±12.9) before percutaneous coronary intervention, and followed them for postoperative 32 months. They reported 144 cases of death, and in patients with increased neutrophil/lymphocyte ratios, higher mortality rates were detected \[[@ref20]\]. In a study performed on non-small cell lung cancer patients who had undergone complete resection, Sarraf et al. detected higher mortality rates in patients with increased neutrophil/lymphocyte ratios \[[@ref21]\]. Uthamalingam et al. divided 1212 patients with diagnosis of acute decompensated heart disease according to their neutrophil/lymphocyte ratios, and found a positive correlation between mortality, and neutrophil/lymphocyte ratios during a median follow-up period of 26 months \[[@ref22]\]. In our study, we also found a correlation between mortality, and neutrophil/leukocyte ratios in patients with aspiration pneumonia which suggests that this parametre can be used as an easily available, simple, and cost-effective marker.

Uric acid is considered as a cardiovascular risk marker \[[@ref23]\]. In a study performed by Tomita et al. the authors reported higher risk of all-cause death (from coronary heart disease, stroke, liver disease and/or renal failure) in 49413 patients aged between 25, and 60 years with uric acid levels over 8.5 mg/dl during a median follow-up period of 5.5 years when compared with those with uric acid levels at 5-6.4 mg/dl \[[@ref24]\]. In our study relationship between uric acid levels, and mortality supports their outcome.

In conclusion, in this study we found increased mortality rates in patients hospitalized with the diagnosis of aspiration pneumonia. Higher number of geriatric patients, and also higher incidence rates of comorbidities may be responsible for higher mortality rates. Neutrophil/lymphocyte ratios (NLR), and uric acid levels can be evaluated as mortality-related factors in cases with aspiration pneumonia.
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